Lawyers in United States

Jennifer Wong

Jennifer Wong is a member of the firm’s Mergers & Acquisitions Practice. Jennifer represents public and private companies in a range of transactions, including: Domestic and cross-border buyouts Mergers and acquisitions Divestitures Asset acquisitions Tender offers Joint ventures Carve-outs General corporate governance matters Jennifer advises clients across a variety of industries, including consumer products, telecommunications, hospitality, retail, and healthcare. In addition to her corporate practice, Jennifer has been engaged in a variety of pro bono efforts, including matters related to advising not-for-profit organizations on formation, corporate governance, and related general corporate matters. Prior to joining Latham, Jennifer was an associate at another leading international law firm.

Latham & Watkins

Jennifer Yang

Jennifer Yang is a partner in the Litigation Department. She is a skilled commercial litigator specializing in false advertising and other intellectual property disputes, including Lanham Act and consumer class action false advertising litigation, advertising challenges before the National Advertising Division (NAD) and National Advertising Review Board (NARB) as well as trademark, trade secret and copyright litigation. Jen represents clients in a variety of industries, including medical device companies, consumer products companies, cosmetics companies, food and beverage companies, fashion retailers, sports, entertainment and art foundations. Jen regularly defends clients in threatened and filed consumer class actions. She has successfully helped clients defend cases around the country involving core product performance claims, ingredient claims, slack fill allegations, environmental and other ESG-related claims, pricing disputes, health claims, and allegations of undisclosed PFAS and other contaminants. Jen has extensive experience litigating matters involving foods, drugs, medical devices, dietary supplements and cosmetics, and is proficient on the impact of the regulatory frameworks governing these products on consumer class action defense. Jen also frequently represents both plaintiffs/challengers and defendants/advertisers in competitor Lanham Act cases and challenges before NAD and NARB. She brings her deep experience in litigation strategy and subject matter expertise to each case to achieve the best possible outcome for her clients. A core part of Jen’s practice includes counseling clients on advertising and claim substantiation. She leverages her expertise in NAD, regulatory guidance (including the FTC Endorsement Guides, Green Guides and Negative Option Rule), state consumer protection statutes and consumer class action trends to work closely with clients and their marketers to help develop compelling marketing campaigns and messaging while minimizing legal risk. Jen also partners with clients’ R&D teams to help develop robust claim substantiation in accordance with best legal practices, including clinical studies, in vitro testing, sensory studies, home use tests, and consumer and expert surveys. Jen is a regular speaker at ANA’s Masters of Advertising Law Conference, and is an author and editor of Proskauer’s advertising law blog, Proskauer on Advertising.

Proskauer Rose LLP

Jennifer Yoo

Jennifer Yoo advises clients active in the healthcare and healthtech sectors on complex regulatory and transactional matters. Jennifer draws on deep regulatory knowledge to counsel public and private companies and investors, including venture capital funds, private equity firms, and underwriters. She helps clients navigate a rapidly evolving healthcare landscape, in particular where new technology and ever-shifting regulations push stakeholders to move at the pace of innovation. She regularly advises clients on matters involving: Healthcare fraud and abuse, including federal and state anti-kickback, false claims, and Stark Law compliance Digital health, telehealth/teleprescribing, and direct-to-consumer health and wellness offerings AI and machine learning in technology-enabled healthcare delivery Strategic counseling for healthcare businesses subject to the Corporate Practice of Medicine doctrine and related fee-splitting regulations for physician and other licensed healthcare professional services Reimbursement strategy and counseling, including on innovative payment models HIPAA and state consumer health data privacy compliance Jennifer provides strategic regulatory counsel in connection with corporate transactions, including mergers, acquisitions, joint ventures, financings, and securities offerings. She helps clients evaluate regulatory risks associated with investments in healthtech and life sciences companies. A trusted strategic advisor, Jennifer also provides litigation support for healthcare-related matters, including white collar defense, government investigations, compliance audits, internal investigations, and voluntary disclosures. Before joining Latham, Jennifer was a partner at another global law firm. She previously served as counsel in Latham’s Los Angeles office from 2019 to 2022 and as an associate from 2007 to 2019.

Latham & Watkins

Jennifer Zepralka

Partner

Mayer Brown

Jenny Austin

Partner

Mayer Brown

Jenny Cieplak

Jenny E. Cieplak advises fintech and financial services clients on a range of corporate, intellectual property, and regulatory issues arising in connection with the development and deployment of new technologies. Jenny provides broad-based corporate counsel to start-ups, financial institutions, investors, and newly created consortiums. She advises clients on collaborative arrangements between users and creators of market infrastructure initiatives designed to transform sectors of the financial industry, including joint development, investment, and governance agreements. Jenny’s insights into the process of technology development, the needs of financial industry users as well as the legal issues surrounding the creation of new technologies and asset classes provide clients with a unique skillset and perspective. Her work includes advising on: The implementation of new technologies, such as artificial intelligence and distributed ledgers, and associated regulatory issues The development and launch of innovative products, such as virtual currencies and digital assets, and ongoing compliance issues associated with the continued development and marketing of such assets Complex joint ventures, including matters focused on entity formation, ownership structure, corporate governance, intellectual property ownership and use, and exit strategies Collaborative technology development arrangements, including joint development and turnkey platform operation agreements Investments in technology startups, including performance-based warrants and other related commercial arrangements The creation, operation, governance, and sale of electronic trading platforms, exchanges, swap execution facilities, clearinghouses, and data repositories

Latham & Watkins

Jenny Cooper

Counsel

Ropes & Gray LLP

Jenny Hochenberg

Freshfields

Jenny L. Holmes

Partner

Nixon Peabody LLP

Jeny Maier

Axinn Managing Partner

Axinn Veltrop & Harkrider

Jeralin Cardoso

Jeralin Cardoso is a seasoned corporate attorney who advises on complex transactions and general corporate matters. She services organizations of all sizes, with a particular focus representing a wide range of clients in the healthcare sector. As co-leader of the Corporate practice group, Jeralin is dedicated to delivering comprehensive, client-focused solutions. Jeralin’s practice encompasses a broad array of matters, including mergers and acquisitions (both buy-side and sell side, and private equity investment and recapitalization transactions), strategic alliances, debt and equity financings, business formation and structuring, corporate governance and other day-to-day operational matters.

Sheppard

Jeremiah (Jeremy) Moffit

Consultant

Withers

Jeremiah Helm

Partner

Knobbe Martens Olson & Bear LLP

Jeremiah M. Wolsk

Corporate Partner

Latham & Watkins

Jeremy A Herschaft

Partner. Maritime, Environmental, Maritime - Environmental, Maritime - Litigation.

Blank Rome LLP

Jeremy A Hushon

Norton Rose Fulbright

Jeremy A. Lieberman

Managing Partner

Pomerantz LLP

Jeremy Andersen

Quinn Emanuel Urquhart & Sullivan, LLP

Jeremy B. Zucker

Dechert

Jeremy Barber

Wilkinson Stekloff

Jeremy Berry

Jeremy Berry is a corporate partner resident in Fried Frank's New York office. Mr. Berry's practice focuses on private investment funds and complex corporate transactions, with a particular focus on private equity and hedge fund formation and other alternative investment matters. Mr. Berry regularly represents some of the most prominent private equity and hedge fund sponsors and investment banks, as well as a broad range of other investment management clients. Mr. Berry consistently advises clients on matters involving private equity and hedge fund formation, fund investment, manager-level transactions and other complex transactions. Mr. Berry brings a global perspective to his investment funds work, which includes a growing practice representing many of the world's largest private equity and hedge fund managers. He provides each client with comprehensive representation; from entity formation through the fundraising process to ongoing operational advice, his knowledge across a range of investment funds structures gives him the ability to keep abreast of emerging trends in the private equity, hedge fund and real estate industries, enhancing the value he provides for his clients. In addition, Mr. Berry also represents institutional investors in the acquisition of positions in private equity, real estate, venture capital and hedge funds. In addition to representing investment fund sponsors and investors, Mr. Berry's practice includes advising clients on investment and financing transactions, with particular emphasis on international or otherwise complex transactions.

Fried, Frank, Harris, Shriver & Jacobson LLP

Jeremy Boczko

Partner

Hunton Andrews Kurth LLP

Jeremy Calsyn

Jeremy Calsyn’s practice focuses on the full range of antitrust matters, including merger review, criminal and civil government investigations globally, and U.S. litigation, including complex class actions. Jeremy has represented clients in their most high-profile and sophisticated matters, including mergers and acquisitions requiring regulatory approval in dozens of jurisdictions, numerous global and U.S.-focused cartel investigations, and in litigation in federal and state courts. Recently, he has navigated several automotive parts suppliers through U.S. Department of Justice and worldwide investigations into industry-wide price fixing—described by the DOJ as the largest criminal investigation it has ever undertaken, and played a major role in arguing the defendants’ successful opposition to class certification in the bearings direct purchaser class action.

Cleary Gottlieb Steen & Hamilton

Jeremy Carroll

Jeremy Carroll is a partner in the Corporate Practice Group in the Chicago office of Kirkland & Ellis LLP and a member of the Financial Institutions and Insurance Transactions & Regulatory Practice Groups. Jeremy’s practice focuses on corporate, securities and regulatory matters in the insurance, reinsurance and financial services industries. Jeremy regularly represents public companies, private companies, private equity sponsors and alternative assets managers in insurance industry transactions, including mergers and acquisitions, reinsurance transactions, joint ventures and strategic investments.

Kirkland & Ellis LLP